Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2025-12-25 @ 12:21 AM
NCT ID:
NCT01269658
Eligibility Criteria:
Inclusion Criteria:
* Have a current diagnosis of blepharitis
* Have a best corrected visual acuity (BCVA), using corrective lenses if
necessary, in both eyes of at least +0.7
* If female, are non-pregnant or non-lactating
Exclusion Criteria:
* Have a concurrent acute hordeolum (stye) or chalazion
* Have inflammation of the ocular surface
* Have used artificial tears within 48 hours prior to Visit 1 or anticipate
using during the study
* Have had ocular surgery in the past 90 days or will require it during the
study
* Unable to withhold the use of contact lenses during the study
* Have a known hypersensitivity to azithromycin, erythromycin, any other
macrolide antibiotic, or any of the other ingredients in the study
medication
* Have been diagnosed with ongoing glaucoma
* Unable to withhold the use of ocular cosmetic products within 48 hours
prior to Visit 1 and throughout the study
* Have a serious medical condition which could confound study assessments
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
14 Years
Maximum Age:
70 Years
Study:
NCT01269658
Study Brief:
Protocol Section:
NCT01269658